CervoMed Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
CervoMed Inc. (CRVO) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $5.34 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2024-08-09
- 2024-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5.34M.
- 2023-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $7.38M.
- 2023-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $9.57M.
- 2023-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$35.11M; Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed $14.23M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2024-03-31 | $5.34M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $7.38M 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $9.57M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$35.11M 10-Q · filed 2024-08-09 | $14.23M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$33.75M 10-Q · filed 2024-05-14 | $16.28M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$33.29M 10-Q · filed 2024-08-09 | $20.22M 10-K · filed 2023-03-24 |
| 2022-09-30 | -$31.84M 10-Q · filed 2023-11-13 | $24.05M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$31.04M 10-Q · filed 2023-11-13 | $26.67M 10-Q · filed 2022-11-14 |
| 2022-03-31 | $30.62M 10-Q · filed 2023-08-08 | |
| 2021-12-31 | -$27.94M 10-K · filed 2024-03-29 | $34.91M 10-K · filed 2022-03-18 |
| 2021-09-30 | $38.13M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $50.17M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $53.65M 10-Q · filed 2022-08-12 | |
| 2020-12-31 | $24.81M 10-K · filed 2023-03-24 | |
| 2020-09-30 | $28.72M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $32.88M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $17.90M 10-Q · filed 2021-08-11 | |
| 2019-12-31 | $20.13M 10-K · filed 2022-03-18 | |
| 2019-09-30 | $13.52M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $16.18M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $12.95M 10-Q · filed 2020-08-07 | |
| 2018-12-31 | $15.61M 10-K · filed 2021-03-17 | |
| 2018-09-30 | $20.91M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $27.30M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $29.72M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $21.23M 10-K · filed 2020-03-17 | |
| 2017-09-30 | $6.36M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.17M 10-Q · filed 2017-08-14 | |
| 2016-12-31 | $9.18M 10-K · filed 2019-03-19 | |
| 2016-09-30 | $11.49M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $14.03M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $16.58M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$41.62K 10-K · filed 2018-04-02 | $16.44M 10-K · filed 2016-03-25 |
| 2015-09-30 | $19.07M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $31.81M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $35.25M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$13.62M 10-K · filed 2017-03-31 | $38.17M 10-K · filed 2015-04-03 |
| 2014-09-30 | $42.80M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $45.30M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $12.22M 10-Q · filed 2014-05-20 | |
| 2013-12-31 | $6.46M 10-K · filed 2016-03-25 | $6.47M 10-K/A · filed 2014-04-23 |
| 2013-09-30 | -$6.34M 10-Q · filed 2013-11-19 | |
| 2013-06-30 | -$8.57M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$19.74M 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | -$18.39M 10-K · filed 2015-04-03 | -$18.41M 10-K/A · filed 2013-04-24 |
| 2012-09-30 | -$6.04M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | -$5.07M 10-Q/A · filed 2012-09-07 | |
| 2011-12-31 | -$16.00M 10-K/A · filed 2013-04-24 | -$112.67K 10-Q/A · filed 2012-09-07 |
| 2011-09-30 | $5.12M 10-Q · filed 2011-11-21 | |
| 2010-12-31 | $20.22K 10-Q · filed 2011-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |